Five-year follow-up on randomized controlled trial of fractionated laser resurfacing as prophylaxis against actinic neoplasia

Affiliations

¹ Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana.
² Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
³ Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Medicine, Dayton Veterans Affairs Medical Center, Dayton, Ohio.
⁴ Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
⁵ Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Medicine, Dayton Veterans Affairs Medical Center, Dayton, Ohio. Electronic address: jeffrey.travers@wright.edu.

Free article

Dan F Spandau et al. J Am Acad Dermatol. 2025.

Free article

. 2025 Sep 5:S0190-9622(25)02751-3.

doi: 10.1016/j.jaad.2025.08.114. Online ahead of print.

¹ Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana.
² Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
³ Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Medicine, Dayton Veterans Affairs Medical Center, Dayton, Ohio.
⁴ Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
⁵ Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Medicine, Dayton Veterans Affairs Medical Center, Dayton, Ohio. Electronic address: jeffrey.travers@wright.edu.

No abstract available

Keywords: actinic keratosis; laser therapy; prophylaxis; skin cancer.

Conflict of interest statement

Conflicts of interest None disclosed.